These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1243126)

  • 41. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Stereotyped movements and substantia nigra-corpus striatum dopaminergic function in the rat: action of methylphenidate after inhibition of monoamine oxidase].
    Duteil J; de Sereville JE; Multon MF; Pessonnier J; Rambert FA
    Ann Pharm Fr; 1987; 45(1):25-34. PubMed ID: 3662339
    [No Abstract]   [Full Text] [Related]  

  • 43. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine.
    Barghon R; Costentin JH
    Eur J Pharmacol; 1980 May; 64(1):39-46. PubMed ID: 6969658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 45. The effects of dopaminergic denervation on Na+-K+ ATPase activity and 3H-ouabain binding in rat corpus striatum.
    Bjur RA; Westfall DP
    Proc West Pharmacol Soc; 1984; 27():35-8. PubMed ID: 6093132
    [No Abstract]   [Full Text] [Related]  

  • 46. Morphine-induced striatal dopamine efflux depends on the activity of nigrostriatal dopamine neurones.
    Moleman P; Bruinvels J
    Nature; 1979 Oct; 281(5733):686-7. PubMed ID: 551287
    [No Abstract]   [Full Text] [Related]  

  • 47. Lesioning the substantia nigra reduces striatal infarct volume following focal ischemia in rats.
    Buisson A; Plotkine M; Boulu R
    Fundam Clin Pharmacol; 1991; 5(7):645-7. PubMed ID: 1778543
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Behavioral evaluation of the unilateral lesion model in rats using 6-hydroxydopamine. Correlation between the rotations induced by D-amphetamine, apomorphine and the manual dexterity test].
    Pavón N; Vidal L; Alvarez P; Blanco L; Torres A; Rodríguez A; Macías R
    Rev Neurol; 1998 Jun; 26(154):915-8. PubMed ID: 9658459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Operant control of turning in circles: a new model of dopaminergic drug action.
    Glick SD
    Brain Res; 1982 Aug; 245(2):394-7. PubMed ID: 6889903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ethanol preference and sterotype behavior of rats.
    Behnert P; Keller G; Andreas K
    Biomed Biochim Acta; 1987; 46(11):841-4. PubMed ID: 3446210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions.
    Gardner EL; Zukin RS; Makman MH
    Brain Res; 1980 Jul; 194(1):232-9. PubMed ID: 6247033
    [No Abstract]   [Full Text] [Related]  

  • 53. Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model.
    Carey RJ
    Brain Res; 1990 May; 515(1-2):292-8. PubMed ID: 2113414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effects of serotonin on turning and sterotypy induced by apomorphine.
    Baldessarini RJ; Amatruda TT; Griffith FF; Gerson S
    Brain Res; 1975 Jul; 93(1):158-63. PubMed ID: 124619
    [No Abstract]   [Full Text] [Related]  

  • 55. The pharmacological and anatomical substrates of the amphetamine response in the rat.
    Creese I; Iversen SD
    Brain Res; 1975 Jan; 83(3):419-36. PubMed ID: 234270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent.
    Koller WC; Weiner WJ; Diamond BI; Nausieda PA; Klawans HL
    Neuropharmacology; 1980 Sep; 19(9):831-7. PubMed ID: 7191490
    [No Abstract]   [Full Text] [Related]  

  • 57. Influence of chronic morphine treatment on dopaminergic sensitivity.
    Lucchelli A; Boselli C; Brunello N
    Pharmacol Res; 1990; 22 Suppl 3():35-6. PubMed ID: 2097635
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of morphine and chlorpromazine on apomorphine-induced stereotyped behavior.
    McKenzie GM; Sadof M
    J Pharm Pharmacol; 1974 Apr; 26(4):280-2. PubMed ID: 4151388
    [No Abstract]   [Full Text] [Related]  

  • 59. Reactions to apomorphine and spiroperidol of rats with striatal lesions: the relevance of kind and size of the lesion.
    Wolfarth S
    Pharmacol Biochem Behav; 1974; 2(2):181-6. PubMed ID: 4597891
    [No Abstract]   [Full Text] [Related]  

  • 60. A potential anti-parkinson drug, N-n-propyl-N-n-butyl-beta-(3,4-dihydroxyphenyl)ethylamine hydrochloride, and its effects in intact and nigra-lesioned rats.
    Ginos JZ; Brown FC
    J Med Chem; 1978 Feb; 21(2):155-60. PubMed ID: 563918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.